Thursday, 02 April 2020

Australia News

  • BioDiem expands antimicrobial profile

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Infectious disease therapies developer, BioDiem has expanded its local partnership network by signing an agreement with Griffith University to expand the range of formulations of...Read more

  • Pharma companies set eyes on China

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    China reported total of 97 deals worth $6.5 billion, the highest in Asia Pacific, according to a mergermarket report. The country was followed by Australia with 40 deals and India and South...Read more

  • Alchemia cancer trial gets nod from drug safety board

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Nov, 2012

    Singapore: Alchemia announced that the independent Data Safety Monitoring Board (DSMB) responsible for reviewing the safety data of Alchemia's phase III, double blind, randomized, pivotal ...Read more

  • Alchemia gets new CEO

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed to the position of Chief Executive Officer. Mr Charles (Charlie) Wa...Read more

  • Doctors now offer GI Dynamic's EndoBarrier Therapy to treat diabetes

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: GI Dynamics announced that doctors at St. Vincent's Clinic and Macquarie University Hospital (MUH) in Sydney now offer EndoBarrier Therapy, a revolutionary, non-surgical, non-ph...Read more

  • What the future holds for the APAC CRO market?

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Indo-Aussie research to find ovarian cancer cure

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Scientists at Australia's Queensland University of Technology (QUT) are hot on the trail of a genetic pathway that regulates ovarian cancer stem cells. The university is collabor...Read more

  • Changes in PBS to help Aussies save $20 mn

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: The listings and price changes that came into effect in Australia this August through the Pharmaceutical Benefits Scheme (PBS) is said to see saving of $20 million a year. Furth...Read more

  • Intl anesthesia society appoints board members

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Dec, 2012

    Singapore: SmartTots, a research initiative sponsored by International Anesthesia Research Society, a non-political medical society that supports anesthesia research and education, has appo...Read more

  • Australian firm registers 25 disease specific stem cell lines at NIH

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Australia's Genea Stem Cells, a supplier and developer of disease-specific human stem cells, has been successful in registering 25 of its disease specific embryonic pluripotent s...Read more

  • Trial begins for vaccine that builds gluten tolerance

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2012

    Singapore: ImmusanT, an early-stage biotechnology company based in Cambridge, Massachusetts, has initiated clinical trials to evaluate Nexvax2, the first therapeutic vaccine for patients wi...Read more

  • Adhesive patch to deliver drugs

    Australia |  News | By Nandita Singh | 0 Comment | 14 Mar, 2012

    One of the promising alternative drug delivery technologies is a transdermal delivery platform called targeted pentration matrix (TPM). Australia-based Phosphagenics has been working to dev...Read more

  • CSL Biotherapies awarded Pandemic Preparedness Contract by US Government

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: CSL Biotherapies has been awarded by the United States (US) Department of Health and Human Services to supply pre-pandemic and pandemic vaccine antigens and related services to t...Read more

  • Uscom signs deal to distribute its devices in China

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Oct, 2013

    Singapore: Australia-based Uscom (Ultrasonic Cardiac Output Monitor) has gained a foothold into the rapidly growing Chinese medical device market after reaching an agreement with China Pion...Read more

  • Scientists discover childhood epilepsy genes

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: National Institute of Health (NIH)-funded genetic study of childhood epilepsies has linked two new genes to severe forms of disease and provides a novel strategy for identifying ...Read more

  • CSL hemophilia therapy gets orphan drug status

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more

  • Genetic Technologies Announces Key Managerial Appointment

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Genetic Technologies announced the appointment of Mr. Mark Ostrowski as Senior Vice President Sales and Marketing Molecular Diagnostics. In this role, Mark will be responsible...Read more

  • IMCD acquires Aussie pharma distributor

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Global distribution firm IMCD Group has acquired Capitol Ingredients Australia, a Sydney headquartered speciality ingredients distributor focused on the nutraceuticals, personal ...Read more